These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7762066

  • 1. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection.
    Spencer A, Brookes PA, Kaminski E, Hows JM, Szydlo RM, van Rhee F, Goldman JM, Batchelor JR.
    Transplantation; 1995 May 15; 59(9):1302-8. PubMed ID: 7762066
    [Abstract] [Full Text] [Related]

  • 2. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 15; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
    Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM.
    Blood; 1995 Nov 01; 86(9):3590-7. PubMed ID: 7579468
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
    Cukrová V, Dolezalová L, Loudová M, Vítek A, Starý J.
    Cas Lek Cesk; 1997 Feb 05; 136(3):80-4. PubMed ID: 9221174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development.
    Dolezalová L, Vraná M, Dobrovolná M, Loudová M, Cukrová V, Vítek A, Sajdová J, Starý J, Sedlácek P.
    Neoplasma; 2002 Feb 05; 49(1):26-32. PubMed ID: 12044056
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun 05; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 11. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A, Allebes WA, Voorter CE, van den Berg-Loonen EM, Schattenberg AV, de Witte TJ, Joosten I.
    Bone Marrow Transplant; 1998 Dec 05; 22(11):1049-55. PubMed ID: 9877266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 05; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
    Kaminski ER, Hows JM, Bridge J, Davey NJ, Brookes PA, Green JE, Goldman JM, Batchelor JR.
    Bone Marrow Transplant; 1991 Jul 05; 8(1):47-50. PubMed ID: 1912955
    [Abstract] [Full Text] [Related]

  • 17. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation.
    Schwarer AP, Jiang YZ, Deacock S, Brookes PA, Barrett AJ, Goldman JM, Batchelor JR, Lechler RI.
    Transplantation; 1994 Dec 15; 58(11):1198-203. PubMed ID: 7992363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E, Tomás JF, Sanz G, Iriondo A, Boqué C, López J, Cabrera R, Sureda A, de Soria VG, Sierra J, Sanz MA, Torres A.
    Haematologica; 2000 May 15; 85(5):530-8. PubMed ID: 10800172
    [Abstract] [Full Text] [Related]

  • 20. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):549-54. PubMed ID: 8722353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.